Trial Details

COMPLETED
Basic Information
Clinical ID c3665
Identifier NCT01699438
Trial Title Mesalazine Treatment in IBS (The MIBS Study)
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Irritable Bowel Syndrome
Interventions DRUG: Mesalazine|DRUG: Placebo
Participant Information
Sponsor Hans Törnblom
City Gothenburg
Country/Region Sweden
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2012-04
Primary Completion Date 2016-12
Completion Date 2017-02